Quince Therapeutics, Inc. (QNCX)
1.165
-0.04
(-2.92%)
USD |
NASDAQ |
May 27, 16:00
1.17
0.00 (0.00%)
After-Hours: 18:43
Quince Therapeutics Free Cash Flow : -39.66M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioXcel Therapeutics, Inc. | -57.38M |
| Gossamer Bio, Inc. | -170.32M |
| Recursion Pharmaceuticals, Inc. | -328.08M |
| Acurx Pharmaceuticals, Inc. | -6.144M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.627M |
| Cash from Investing (Quarterly) | 12.00M |
| Cash from Financing (Quarterly) | 9.443M |
| Free Cash Flow Per Share (Quarterly) | -0.8299 |
| Free Cash Flow to Equity (Quarterly) | 10.44M |
| Free Cash Flow to Firm (Quarterly) | -7.627M |
| Free Cash Flow Yield | -548.4% |